Cancer Genomics Consortium (CGC) is a 501(c)3 non-profit organization whose mission is to providing high quality education and promoting best practices in clinical cancer genomics. Our vision is that all cancer patients will be accurately diagnosed for their underlying genomic alterations to help them receive the most appropriate therapy. CGC will be the authoritative organization for guidance on the best practice of clinical cancer genomic testing.